TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIA
- 1 April 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 325 (8434), 885-888
- https://doi.org/10.1016/s0140-6736(85)91670-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected withP. bergheiand‘P. bergheiNS’Pathogens and Global Health, 1984
- A PHASE-II CLINICAL-TRIAL OF MEFLOQUINE IN PATIENTS WITH CHLOROQUINE-RESISTANT FALCIPARUM-MALARIA IN THAILAND1983
- A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of FansidarTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- Chemosuppressive Field Trials in ThailandThe American Journal of Tropical Medicine and Hygiene, 1980
- The inhibitory effect of a drug combination on the development of mefloquine resistance inPlasmodium bergheiPathogens and Global Health, 1980
- SINGLE-DOSE THERAPY OF FALCIPARUM-MALARIA WITH MEFLOQUINE OR PYRIMETHAMINE-SULFADOXINE1979
- Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.BMJ, 1977
- Mefloquine (WR 142,490) in the Treatment of Human MalariaScience, 1975